Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report

Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubuloin...

Full description

Saved in:
Bibliographic Details
Published inRespirology case reports Vol. 11; no. 8; pp. e01190 - n/a
Main Authors Moussa, Chirine, Esbaa, Samia, Rouis, Houda, Sellami, Nada, Hajji, Meriam, Houcine, Yoldez, Khattab, Amel, Khouaja, Ibtihel, Zendah, Ines, Maâlej, Sonia
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.08.2023
John Wiley & Sons, Inc
Wiley
Subjects
acute kidney injury
acute renal failure
acute tubulointerstitial nephritis
Biopsy
Blood
Case Report
Case Reports
Creatinine
Drug dosages
Drug resistance
Kidneys
Necrosis
Patients
Pharmacovigilance
rifampicin
Tuberculosis
rifampicin
acute kidney injury
acute renal failure
acute tubulointerstitial nephritis
tuberculosis
Online AccessGet full text

Cover

More Information
Summary:Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges. We present a case of rifampicin‐induced acute renal failure due to acute tubulointerstitial nephritis (ATIN), successfully managed with second‐line anti‐TB treatment.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
content type line 23
ObjectType-Report-1
Associate Editor: Andrea Ban Yu‐Lin
ISSN:2051-3380
2051-3380
DOI:10.1002/rcr2.1190